Related Experiment Videos

Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study

Masumi Ai1, Seiko Otokozawa, Bela F Asztalos

  • 1Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.

Atherosclerosis
|July 12, 2011
PubMed

Insights

Higher plasma adiponectin levels predict lower coronary heart disease (CHD) risk in Caucasian men. This finding suggests adiponectin is an independent predictor of cardiovascular health in men.

Area of Science:

  • Cardiovascular Disease Research
  • Endocrinology
  • Biomarker Discovery

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Identifying reliable predictors of CHD risk is crucial for effective prevention strategies.
  • Adiponectin, an adipokine, has been investigated for its role in metabolic and cardiovascular health.

Purpose of the Study:

  • To investigate whether plasma adiponectin levels serve as an independent predictor of coronary heart disease (CHD) risk.
  • To analyze the association between adiponectin levels and future CHD events in a cohort study.

Main Methods:

  • Plasma adiponectin levels were measured using a fully automated assay in 3188 participants from the Framingham Offspring Study.
  • Participants (mean age 57 years) were followed for a mean of 7.5 years for CHD events.
  • Statistical analyses included adjustments for multiple cardiovascular risk factors and inflammatory markers.

Main Results:

  • Plasma adiponectin levels were significantly higher in women than in men.
  • In men, higher plasma adiponectin levels were a significant independent predictor of lower future CHD risk (HR 0.49, p<0.0022) after multivariate adjustments.
  • A similar trend was observed in women, but did not reach statistical significance after adjustments.

Conclusions:

  • Plasma adiponectin levels are an independent predictor of CHD risk in Caucasian men without prior CHD.
  • The findings highlight the potential of adiponectin as a biomarker for cardiovascular risk assessment in men.
  • Further research may explore the mechanisms underlying adiponectin's protective role in men's cardiovascular health.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...